PeptideStack
5.2kquestions
20kanswers
220users

Is a list of related substances from GGPeps sufficient basis to skip independent testing?

Asked 28 Jun 2026Modified 1 min agoViewed 4.8k times
4

Conditions: list of related substances · GGPeps.

I want to decide this in advance so that I am not deciding it under pressure later.

Assume I will follow the plan I write down, so I would like it to be a good one.

What would you do, and what would make you change course?

coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

749 questions
batch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

865 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

445 questions
residual-solvent
residual-solvent

Solvents left behind by synthesis and purification - acetonitrile, TFA, DMF, DCM - their ICH limits, how they are measured by headspace GC, and…

14 questions
shareeditfollowflag
HP
askedh_pergande86k25828 Jun 2026

5 Answers

Accepted answer first, then by votes
20

Accepted answer

The certificate is not the answer to your question; it is a data point that you need to combine with other information to build an answer.

The test date matters because a certificate six months older than the vial is not evidence about your material, it is evidence about what the material was like half a year ago.

What each test answers

TestAnswersDoes NOT answer
RP-HPLC, area %What fraction of detected material is the targetHow much target is present
Quantified contentMilligrams of peptide per vialWhat the impurities are
ESI-MS identityWhether the molecular weight matchesPurity, or isomeric substitution
Peptide mappingSequence, localised to a fragmentQuantity
Karl FischerWater content of the solidSolvent content
LAL endotoxinPyrogen load in EU/mgSterility
Sterility testGrowth in defined media over 14 daysEndotoxin, or bioburden count

Test results from a material supplier are different from independent results in ways that matter for interpretation, even if both are accurate.

Industry guidance on this topic is consistent because it comes from first principles rather than convention.

One qualification: a single result from a single vial at a single time is a point estimate with no error bar, and no amount of decimal places changes that.

If the certificate does not trace to your vial, it is not evidence about your vial.

edited 6 Aug 2026 by tenth_of_a_unit — expanded the table to cover the lower concentration

shareimprove this answerflag
TU
answered · acceptedtenth_of_a_unit40k388 Jul 2026
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards
21

Specifically, reading a certificate means checking four things before anything else: traceability to your vial, the test date, the analytical method, and the identity of the testing laboratory.

Multiple testing on the same lot reported in a single document suggests internal quality control; identical figures across different lots suggests the same certificate reused.

The part that matters: a purity figure to two decimal places with no supporting chromatogram is giving false precision and is a red flag on the same level as spelling errors.

The limitation is cost — truly rigorous testing on every lot is expensive enough that most people do not do it, which is exactly why the variation matters.

The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.

shareimprove this answerflag
LT
answeredlane_transit42k3814 Jul 2026
3Thank you — the worked example is what makes this usable. – ines_brandt 5 months ago
2Related: the same reasoning applies to the counter-ion question. – esther_vandeVelde 4 months ago
add a comment
13

What makes a certificate useful is not its appearance but whether you could hand it to another laboratory and they would reproduce the result.

A method section that differs markedly from pharmacopoeial standards is either innovative or nonstandard, and distinguishing the two requires expertise.

Put another way, the laboratory name and accreditation status can be checked in real time against the testing service's own register, and that two-minute check catches substituted certificates.

Published inter-laboratory comparisons of the same material routinely find spreads of half a per cent to a full per cent, which sets realistic expectations.

My working rule is that a document without a lot number, a method section and a test date is marketing.

shareimprove this answerflag
MO
answeredmarta_okonkwo87k25817 Jul 2026
8

The underlying point is that most certificates are written to look impressive rather than to be informative, and it is worth being sceptical of that gap.

The certificate is a snapshot and nothing else — it tells you about the material on one day from one sample of one lot, and extrapolation beyond that requires logic.

Pharmacopoeial standards require method validation steps that research-grade certificates almost never claim to meet, and the absence of that claim is itself information.

Worth noting that none of this is medical advice, and a compound sold for research use carries no regulatory approval in any jurisdiction.

If the certificate does not trace to your vial, it is not evidence about your vial.

shareimprove this answerflag
LM
answeredlucia_marchetti18k281 Jul 2026
7

The part that matters: the most common trap is reading a certificate as if it were a guarantee when it is actually a single point estimate from a single test.

Comparison across certificates from different laboratories is almost never valid, even when the material is the same, because the methods are almost never the same.

Research-grade certificates carry no regulatory backing and no standing in quality systems, and that limitation is worth being explicit about.

The caveat is that a certificate is not a guarantee, it is a data point, and treating it as anything else is asking for disappointment.

The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.

shareimprove this answerflag
DS
answeredDr_Hanne_Solberg40k3811 Jul 2026
8Related: the same reasoning applies to the counter-ion question. – kirsi_lahtinen 2 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.